Sun Pharmaceutical Industries Limited (“Company”) has entered into an agreement to acquire 60% shareholding in Vivaldis Health And Foods Private Limited from its existing shareholders with remaining 40% shareholding to be acquired in future as per certain terms & conditions.
Vivaldis Health And Foods Private Limited (“Target”), is engaged in the business of trading, distributing, manufacturing and marketing of drugs, food supplements and over the counter products in the companion animal segment of animal healthcare industry. The revenue for the financial year 2021-22 was INR 29.92 crores.
The Company will pay a cash consideration of INR 143.30 crores subject to customary closing adjustments for 60% (sixty percent) shareholding.
Be First to Comment